AI-Generated Summary
Invests in
Sectors:
Locations:
Min Investment:
$500,000.00Max Investment:
$15,000,000.00Target Investment:
$7,000,000.00
Skills
Education
- SU
- SU
- MC
Lists including Nicholas
Work Experience
2016
Senior Principal
2023
Principal
2020 - 2023
Senior Associate
2018 - 2020
Associate
2017 - 2018
Consultant
2016 - 2017
VentureLabs Fellow
2016 - 2016
2017
Advisor
2022
Founding Team, Chief Innovation Officer
2017 - 2022
Cellarity develops novel medicines that are unreachable with traditional methods of drug discovery, completely revolutionizing the way drugs are created.
2020 - 2023
Advisor
2022 - 2023
Founding Team
2020 - 2022
Abiologics, Inc. is a privately held, early-stage biotechnology company on a mission to make biology better through chemistry. We are pioneering the development of a transformational new class of medicines that is unlocked by novel synthetic and computational technologies.
2021 - 2022
Founding Team
2021 - 2022
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else.
2017 - 2019
Founding Team
2017 - 2019
2017 - 2018
Founding Team
2017 - 2018
Ring Therapeutics is revolutionizing the gene therapy and nucleic acid medicine space by harnessing the most abundant and diverse member of the human commensal virome, anelloviruses.
2013 - 2016
Vice President
2015 - 2016
Scientific and Market Advising in the Life Sciences
Engagement Manager
2014 - 2015
Analyst
2013 - 2014
2010 - 2011
Research Assistant
2010 - 2011
Department of Chemistry and Biochemistry, Laboratory of Dr. James Larrabee
2008 - 2009
Research Assistant
2008 - 2009
Departments of Chemistry and Radiology, Laboratory of Dr. Peter Caravan